Huang Q, Chen H, Ren Y, Wang Z, Zeng P, Li X, Wang J, Zheng X. Anti-hepatocellular carcinoma activity and mechanism of chemopreventive compounds: ursolic acid derivatives.
PHARMACEUTICAL BIOLOGY 2016;
54:3189-3196. [PMID:
27564455 DOI:
10.1080/13880209.2016.1214742]
[Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/25/2015] [Accepted: 07/13/2016] [Indexed: 06/06/2023]
Abstract
CONTEXT
Hepatocellular carcinoma (HCC) is a common cancer around the world, with high mortality rate. Currently, there is no effective drug for the therapy of HCC. Ursolic acid (UA) is a natural product which exists in various medicinal herbs and fruits, exhibiting multiple biological effects such as its outstanding anticancer and hepatoprotective activity, which has drawn many pharmacists' attention.
OBJECTIVE
This paper summarizes the current status of the hepatoprotective activity of UA analogues and explains the related mechanism, providing a clear direction for the development of novel anti-HCC drugs.
METHODS
All of the data resources were derived from PubMed. By comparing the IC50 values and analyzing the structure-activity relationships, we listed compounds with good pharmacological activity from the relevant literature, and summarized their anti-HCC mechanism.
RESULTS
From the database, 58 new UA derivatives possessing wonderful anticancer and hepatoprotective effects were listed, and the relevant anti-HCC mechanism were discussed.
CONCLUSION
UA's anti-HCC effect is the result of combined action of many mechanisms. These 58 new UA derivatives, particularly compounds 45 and 53, can be used as potential drugs for the treatment of liver cancer.
Collapse